4W9P
The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-[(1S)-1,2-dihydroxyethyl]-3-[2-(3,4-dimethoxyphenoxy)ethyl]-3,10-diazabicyclo[4.3.1]decan-2-one
4W9P の概要
エントリーDOI | 10.2210/pdb4w9p/pdb |
分子名称 | Peptidyl-prolyl cis-trans isomerase FKBP5, (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-[(1S)-1,2-dihydroxyethyl]-3-[2-(3,4-dimethoxyphenoxy)ethyl]-3,10-diazabicyclo[4.3.1]decan-2-one, ACETATE ION, ... (4 entities in total) |
機能のキーワード | fk-506 binding domain, hsp90 cochaperone, immunophiline, peptidyl-prolyl isomerase, ligand selectivity, isomerase |
由来する生物種 | Homo sapiens (Human) |
細胞内の位置 | Cytoplasm: Q13451 |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 29377.27 |
構造登録者 | Pomplun, S.,Wang, Y.,Kirschner, K.,Kozany, C.,Bracher, A.,Hausch, F. (登録日: 2014-08-27, 公開日: 2014-12-03, 最終更新日: 2024-01-10) |
主引用文献 | Pomplun, S.,Wang, Y.,Kirschner, A.,Kozany, C.,Bracher, A.,Hausch, F. Rational Design and Asymmetric Synthesis of Potent and Neurotrophic Ligands for FK506-Binding Proteins (FKBPs). Angew.Chem.Int.Ed.Engl., 54:345-348, 2015 Cited by PubMed Abstract: To create highly efficient inhibitors for FK506-binding proteins, a new asymmetric synthesis for pro-(S)-C(5) -branched [4.3.1] aza-amide bicycles was developed. The key step of the synthesis is an HF-driven N-acyliminium cyclization. Functionalization of the C(5) moiety resulted in novel protein contacts with the psychiatric risk factor FKBP51, which led to a more than 280-fold enhancement in affinity. The most potent ligands facilitated the differentiation of N2a neuroblastoma cells with low nanomolar potency. PubMed: 25412894DOI: 10.1002/anie.201408776 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.5 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
